Bill Of Health

JULY 20, 2022

Section 340B of the Public Health Service Act requires that pharmaceutical manufacturers give discounts on specified outpatient drugs to certain covered entities who typically serve low-income or otherwise underserved patients, including hospitals and clinics. billion and accounting for a third of U.S.

Pharmaceuticals 57

Pharmaceuticals Hospitals Public Health services Accountability 57

Sheppard Health Law

FEBRUARY 22, 2023

All rebate payments will be deposited into the Medicare Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund. Is the Guidance Final or Open to Comment? Interestingly, the answer is – both. 9, 2023). [2]

Medicare 52

Medicare Medicaid Pharmaceuticals Public Health services 52

Sheppard Health Law

AUGUST 25, 2022

With respect to biological products, however, such drugs must be licensed in accordance with the Public Health Service Act (“PHSA”) for at least 11 years, and marketed in conformance with the PHSA. A safe harbor applicable to flat fee arrangements paid by pharmaceutical manufacturers directly to PBMs for PBM services.

Healthcare 52

Healthcare Medicare Pharmaceuticals Medicaid 52